Alliance Wealth Advisors (Utah)’s Biogen BIIB Stock Holding History

Alliance Wealth Advisors (Utah)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,072	Closed	-$402K	–	259
2024 Q3	$402K	Buy	2,072 +53	+3%	+$11.1K	0.11%	174
2024 Q2	$468K	Sell	2,019 -4	-0.2%	-$869	0.14%	142
2024 Q1	$436K	Buy	2,023 +62	+3%	+$14.5K	0.13%	158
2023 Q4	$507K	Buy	1,961 +32	+2%	+$7.86K	0.17%	125
2023 Q3	$496K	Buy	1,929 +16	+0.8%	+$4.28K	0.18%	118
2023 Q2	$545K	Buy	1,913 +126	+7%	+$37.5K	0.2%	115
2023 Q1	$497K	Buy	1,787 +28	+2%	+$7.75K	0.2%	117
2022 Q4	$487K	Buy	+1,759	New	+$497K	0.22%	111

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alliance Wealth Advisors (Utah)'s BIIB Position: Q4 2024 in Review

Alliance Wealth Advisors (Utah) sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,072 shares — an estimated $402K sold.

Alliance Wealth Advisors (Utah) first reported a position in BIIB in Q4 2022 and held it in 8 quarters. The position peaked at $545K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

Alliance Wealth Advisors (Utah) reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
Alliance Wealth Advisors (Utah) sold 2,072 Biogen shares in Q4 2024, an estimated $402K.
Alliance Wealth Advisors (Utah) first reported a position in Biogen in Q4 2022 and held it in 8 quarters.
Alliance Wealth Advisors (Utah)'s Biogen position peaked at $545K in Q2 2023.
876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q4 2024, filed 24 Jan 2025.